D. Aronson

发表

Chromatographic analysis of the activation of human prothrombin with human thrombokinase.

D. Aronson, D. Ménaché, 1966, Biochemistry.

Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma.

A. P. Ball, J. Finlayson, L. Stevan, 1977, The Journal of clinical investigation.

Plasma proteins for therapeutic use: past, present and future

J. Finlayson, D. Aronson, 1985 .

Tumor cell generation of thrombin via functional prothrombinase assembly.

K. Mann, H. Dvorak, P. Tracy, 1985, Cancer research.

Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease.

J. M. Carr, J. Mcdonagh, L. Vandewater, 1986, Blood.

An automated fibrinolytic assay performed in microtiter plates.

D. Beebe, D. Aronson, 1987, Thrombosis research.

Turnover of tPA in rabbits: influence of carbohydrate moieties.

D. Beebe, D. Aronson, 1988, Thrombosis research.

Turnover of human tissue plasminogen activator (tPA) in rabbits.

D. Beebe, D. Aronson, 1986, Thrombosis research.

Human prothrombin fragments FI(αβ) and F2: Preparation and characterization of structural and biological properties☆

J. Fenton, T. Hugli, D. Aronson, 1980 .

Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis

C. Kessler, R. Montgomery, J. Gill, 1996, British journal of haematology.

Alteration of fibronectin receptors (integrins) in phorbol ester-treated human promonocytic leukemia cells.

L. Van De Water, D. Aronson, V. Braman, 1988, Cancer research.

Some properties of antithrombin-III and its concentration in human plasma.

G. Murano, M. Miller-Andersson, D. Aronson, 1980, Thrombosis research.

Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura

S. Leitman, M. Rick, H. Austin, 2004, American journal of hematology.

Crosslinking of Rabbit Fibrin in Vivo

J. Finlayson, D. Aronson, 1974, Thrombosis and Haemostasis.

The inhibition of high and low molecular weight urokinase in plasma.

L. Brown, G. Murano, D. Aronson, 1980, Blood.

Cause of death in hemophilia a patients in the United States from 1968 to 1979

D. Aronson, 1988, American journal of hematology.

Contact-activated factors: contaminants of immunoglobulins preparations with coagulant and vasoactive properties.

J. Finlayson, B. Alving, D. Aronson, 1980, The Journal of laboratory and clinical medicine.

Activated Factor VIII inTherapeutic Preparations:Analysis by Ultracentrifugation

P. Chang, D. Aronson, 1996, Vox sanguinis.

Platelet‐Dependent Thrombin Generation After In Vitro Fibrinolytic Treatment

C. Kessler, D. Aronson, P. Chang, 1992, Circulation.

Human α-Thrombin Preparations

M. Zabinski, J. Finlayson, J. Fenton, 1977, Thrombosis and Haemostasis.

Heterogeneity of factor IX in therapeutic factor IX concentrates.

D. Aronson, D. Ménaché, 1978, Thrombosis research.

In vivo consumption of prothrombin during clot formation: an "all or none" phenomenon.

D. Aronson, 1985, Thrombosis research.

New Treatments of von Willebrand Disease: Plasma Derived von Willebrand Factor Concentrates

D. Aronson, D. Ménaché, 1997, Thrombosis and Haemostasis.

Enzyme alteration by ionizing radiation.

D. Aronson, M. J. Fraser, C. L. Smith, 1956, Radiation research.

Soil sampling in an urban focus of histoplasmin sensitivity.

L. Ajello, P. Q. Edwards, D. Aronson, 1960, The American review of respiratory disease.

An urban focus of histoplasmin sensitivity.

P. Q. Edwards, D. Aronson, 1959, American review of tuberculosis.

Purification of human factor X and comparison of peptide maps of human factor X and prothrombin.

D. Aronson, J. Mushinski, A. Mustafa, 1969, Biochimica et biophysica acta.

Activation of human prothrombin by a procoagulant fraction from the venom of Echis carinatus. Identification of a high molecular weight intermediate with thrombin activity.

J. Finlayson, D. Aronson, B. R. Franza, 1975, The Journal of biological chemistry.

Action of human thrombokinase on human prothrombin and p-tosyl-l-arginine methyl ester.

D. Aronson, D. Ménaché, 1968, Biochimica et biophysica acta.

Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long‐term warfarin therapy and those in the initial phase

D. Weinstock, P. Chang, D. Aronson, 1998, American journal of hematology.

Clinical Use of a Rapid Collagen Binding Assay for von Willebrand Factor Cleaving Protease in Patients with Thrombotic Thrombocytopenic Purpura

G. White, M. Rick, M. Taylor, 2002, Thrombosis and Haemostasis.

Infection of hemophiliacs with HIV

D. Aronson, 1993, Journal of clinical apheresis.

A Rapid Assay for the vWF Protease

M. Rick, D. M. Krizek, D. Aronson, 2001, Thrombosis and Haemostasis.

Prothrombin profragment-1 optical rotatory dispersion and circular dichroism.

D. J. Schaefer, K. Koehler, D. Gabriel, 1975, Thrombosis research.

Coagulant proteins and thrombin generation in synovial fluid: A model for extravascular coagulation

D. Borenstein, P. Chang, D. Aronson, 1995, American journal of hematology.

N-Terminal Amino-Acids formed during the Activation of Prothrombin

D. Aronson, 1962, Nature.

Molecular weights of human prothrombin and thrombin by electron irradiation.

J. Preiss, D. Aronson, 1962, Radiation research.

Physical Studies on Isolated Human Prothrombin Fragment-2. Comparisons with Human Prothrombin Fragment-1

R. Hiskey, K. Koehler, D. Aronson, 1979, Thrombosis and Haemostasis.

Measures to inactivate viral contaminants of pooled plasma products.

D. Aronson, D. Ménaché, 1985, Progress in clinical and biological research.

Serologic Evidence for Hepatitis B Virus Infection in Patients with Hemophilia B

J. Hoofnagle, D. Aronson, H. Roberts, 1975, Thrombosis and Haemostasis.

The purification of human acarboxy prothrombin. Characterization of its derivatives after thrombin cleavage.

A. Bezeaud, N. Schlegel, D. Aronson, 1977, Thrombosis research.

A urokinase-incubation method for predicting the stability of immune globulin.

J. Finlayson, D. Aronson, A. M. Young, 1978, Journal of biological standardization.

Prevention of infectious disease transmission by blood and blood products.

D. Aronson, D. Ménaché, 1987, Progress in hematology.

The use of prothrombin activating snake venoms to measure human prethrombin 2: absence of prethrombin 2 in serum.

D. Aronson, B. R. Franza, J. Bagley, 1984, Thrombosis research.

Identification of a Prothrombin Derivative in Human Urine

A. Bezeaud, D. Aronson, D. Ménaché, 1977, Thrombosis and Haemostasis.

Purification and Characterization of Activation Fragments F1 and F2 from Human Prothrombin

A. P. Ball, J. Fenton, D. Aronson, 1975, Thrombosis and Haemostasis.

Ultracentrifugal Analysis of Factor VIII and von Willebrand Factor in Therapeutic Preparations

P. Chang, D. Aronson, 1995, Vox sanguinis.

Molecular Weights of Factor VIII (AHF) and Factor IX (PTC) by Electron Irradiation

M. Mosesson, J. Preiss, D. Aronson, 1962, Thrombosis and Haemostasis.

Contact-Activated Factors: Contaminants of Immunoglobulin Preparations with Vasoactive and Coagulant Properties

J. Finlayson, B. Alving, D. Aronson, 1979, Thrombosis and Haemostasis.

Detection and measurement of low levels of prothrombin. Use of a procoagulant from Echis carinatus venom.

D. Aronson, B. R. Franza, 1976, Thrombosis research.

Thrombogenicity of factor IX complex: in vivo investigation.

D. Aronson, D. Ménaché, 1987, Developments in biological standardization.

International Collaborative Study on the Assay of Commercially Available High and Low Molecular Weight Urokinases

T. Kirkwood, P. Gaffney, G. Murano, 1981, Thrombosis and Haemostasis.